Prostate Cancer International is
for 2011 by Great NonProfits
Perspective Confidentiality Disclosure Reliability Courtesy
According to new data from a study at the University of Chicago, African-American males scheduled for a prostate biopsy are at greater risk for a positive diagnosis of cancer than white males and they also significantly underestimate their probability of a positive biopsy result.
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: belief, biopsy, ethnicity, outcome, race, risk | Leave a Comment »
A review article on issues affecting perceptions of prostate cancer among Black men of African, Afro-Caribbean, and African American ethnicity has highlit the very limited data available about prostate cancer, its diagnosis, and its management in males from specific ethnic groups inside and outside the USA.
Filed under: Diagnosis, Management, Risk | Tagged: Australia, black, ethnicity, indigenous, native American | Leave a Comment »
One of the other major initiatives that have been funded over several years by the Department of Defense’s Prostate Cancer Research Program is the North Carolina-Louisiana Prostate Cancer Project (often just known as PCaP).
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: Diagnosis, disparities, ethnicity, race, risk | Leave a Comment »
In today’s news reports we cover items on: Risks for prostate cancer from smoking and increased adipose tissue The role of religious activities in prostate cancer testing among African Americans Blood loss at the time of surgery and risk for progressive disease
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: adipose, blood loss, BMI, body mass index, DRE, ethnicity, recurrence, religion, risk, smoking | Leave a Comment »
The differences in risk for and mortality from prostate cancer across racial and ethnic lines have been well documented.However, there has been continuing controversy over the degree to which socioeconomic status (SES) may be able to account for these differences.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: ethnicity, mortality, race, risk | Leave a Comment »
There has been a positive plethora of news reports over the past 24 hours, starting with the very important issuance of the AUA/ASCO guideline on the potential use of 5-ARIs for the prevention of prostate cancer. This will be just the first of at least three groups of news reports today! This report deals with: [...]
Filed under: Diagnosis, Drugs in development, Risk | Tagged: ethnicity, IGF-I, insulin-like growth factor I, phenoxodiol, PSA, race, sarcosine research test, variants | Leave a Comment »
The issue of whether race and socioeconomic status impact prostate cancer treatment outcomes is fraught with all sorts of pitfalls: emotional, statistical, political, medical, societal, you name it.
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: ethnicity, outcome, race, risk, socioeconomic status | Leave a Comment »
There are several interesting news items today, as follows: Ethnic variation in the performance of PSA and PSA density as markers for risk of prostate cancer Potential underuse of active surveillance in eligible patients Application of active surveillance in a 40-patient case series The potential to eliminate the need for a urethral (Foley) catheter post-surgery [...]
Filed under: Diagnosis, Management, Treatment, Uncategorized | Tagged: active, androgen, cancer, catheter, CTC, density, deprivation, ethnicity, news, prostate, PSA, race, surveillance, update | 1 Comment »
Search for new and
ongoing trials on the
CTAG PCa web site